Skip to main content

Table 2 Key feasibility indicators for progression [48, 49]

From: Transcutaneous auricular vagus nerve stimulation for the treatment of myoarthropatic symptoms in patients with craniomandibular dysfunction – a protocol for a randomized and controlled pilot trial

Key indicator

Go—proceed with RCT

Amend—proceed with changes

Stop—do not proceed unless changes are possible

Recruitment rate

Target figure: 20 participants

 ≥ 70% of target number

51–69% of target number

 ≤ 50% of target number

Retention rate

75% of the participants randomized to intervention group will complete outcome measures T0, T1, and T2

 ≥ 70% of target number

51–69% of target number

 ≤ 50% of target number

Compliance

 ≥ 80% of target number use the stimulator for at least 2 h (mean) per day

61–79% of target number use the stimulator for at least 2 h (mean) per day

 ≤ 60% of target number use the stimulator for at least 2 h (mean) per day